Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | C P THAKKAR AND COMPANY (PHARMA) LIMITEDLikely | RA Ended | 1 | ₹1.2 L |
| 2 | Schedule 2 | C P THAKKAR AND COMPANY (PHARMA) LIMITEDLikely | RA Ended | 1 | ₹62,925 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 May 2024, 9:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
HUMAN METRACELL DERMAL MESH 97% DNA FREE 3X3 (Q3)
HUMAN METRACELL DERMAL MESH 97% DNA FREE 2X2 (Q3)
6312083
GEM/2024/B/4861198
Two Packet Bid
HUMAN METRACELL DERMAL MESH 97% DNA FREE 3X3,HUMAN METRACELL DERMAL MESH 97% DNA FREE 2X2
30 days
Maharashtra; Mumbai
Item wise evaluation
PRODUCT_CUSTOM
5 documents required · 5 mandatory
2 yrs
₹3
20%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| HUMAN METRACELL DERMAL MESH 97% DNA FREE 3X3 (Q3) | MUMBAI | 3 | 30 days | |
| HUMAN METRACELL DERMAL MESH 97% DNA FREE 2X2 (Q3) | MUMBAI | 3 | 30 days |
Exempted
11 May 2024
19 Apr 2024
11 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6312083.pdf
GEM_BID
adobe_scan_15_apr_2024_2024-04-15-09-52-10_181ffd164101f2a2d9382197191a3ec8.pdf
SPECIFICATION
adobe_scan_15_apr_2024_2024-04-15-09-54-01_b8b7a940ee640062a17c120bddbde803.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .